Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Erysaa (epoetin alfa biosimilar) / PanGen Biotech, CCM Pharma
PDA10a: CCM Duopharma Biotech Berhad To Commence Historic Phase III Clinical Trials For Treatment Of Kidney Failure	Ongoing	3	300	Malaysia	PDA10 (epoetin alfa biosimilar)	PanGen Biotech	Kidney Failure